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CORRESPONDENCEThe Changing Incidence of Femoral Artery
Pseudoaneurysm
We read with interest the article by Norwood and
colleagues.1
The management of femoral artery pseudoaneur-
ysm has evolved in recent years and percutaneous
ultrasound guided thrombin injection is now rec-
ommended as the standard of care. Its efficacy is
highlighted by successful pseudoaneurysm thrombo-
sis in 96% of cases and good patient tolerance.2,3
As described by Norwood, potential reasons for a
change in femoral artery pseudoaneurysm incidence
may be related to an increased number of interven-
tional cardiological procedures performed coupled
with the newer anti-platelet agents now employed.
We have recently undertaken a review of 87 patients
with89 iatrogenic pseudoaneurysm treated at our centre
between January 1997 and June 2002.4 Thrombin
injection was introduced as a treatment modality from
July 1999. Prior to this, compression therapy and
conventional operative repair were utilised in the
management of pseudoaneurysm. In the two years
(1997–1998) before the introductionof thrombin therapy,
17 (89%)of 19 lesionswere repaired surgically. In the two
years (2000–2001) after its introduction, 21 (41%) of 51
required operation. While there was no significant
increase in the total number of arterial catheterisations,
therewere significantlymore pseudoaneurysms treated
after July 1999; thepoint atwhich thrombin injectionwas
introduced as a treatment option.
Findings of an increased number of pseudoaneur-
ysms referred and treated together with a constant
incidence of surgical repair for pseudoaneurysm
suggest that a lower threshold for treatment by
thrombin injection exists; and may account for the
increased incidence seen in our series and that of
Norwood and colleagues.
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http://www.sciencedirect.com onPseudoaneurysm of the Femoral Artery in a
HIV-infected Man
Arterial pseudoaneurysms are extremely rare findings
in human immunodeficiency virus (HIV) infected
patients. However, prolonged survival and the
accumulation of cardiovascular risk factors (i.e. ather-
osclerosis, arterial blood hypertension, dyslipidemia)
observed in patients on highly active antiretroviral
regimens (HAART) can lead to an increased risk of
vascular complications.1–3
We report here the case of a 56-year-old bisexual
man, HIV-infected since June 1991, never followed at
any HIV care centre until November 1997, when he
developed cerebral toxoplasmosis. After hospitaliz-
ation, HAART containing stavudine, didanosine and
indinavir was started with immunological and virolo-
gical improvement (November 1997, CD4C: 9
cell/mmc, HIV-RNA: 66460 copies/ml, measured by
NASBA technique; July 1998, CD4C: 187 cell/mmc,
HIV-RNA: 4340 copies/ml). HIV-RNA plasma levels
became undetectable in December 1998 and since then
plasma viremia remained below detection limits;Eur J Vasc Endovasc Surg 28, 451–454 (2004)
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